Chir-258
Adenocarcinoma, Scirrhous
Novartis PharmaceuticalsPhase 2
—
Rating in progress
Chir-258 in Adenocarcinoma, Scirrhous is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant